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Summary 
Natural killer (NK) cells express a repertoire of killer cell inhibitory receptors (KIR) for major 
histocompatibility complex (MHC) class I molecules. KIR specificity for MHC class I can be 
broad, as in the case of a single p70 KIR that can recognize several HLA-B allotypes, including 
HLA-B*2705. On the other hand, recognition of MHC class I can also be highly specific, as in 
the case  of NK clones that recognize HLA-B*2705 in a peptide-specific manner.  Most NK 
cells  express multiple KIR sequences. To determine whether the broad and specific types of 
HLA-B recognition by NK cells reflect the use of different receptors or a property of a single 
KIIK we analyzed the recognition of HLA-B*2705 by the p70 KIR-11, known to recognize 
several HLA-B allotypes. Vaccinia virus-mediated expression of KIR-11 in NK clones resulted 
in inhibition by HLA-B*2705 molecules on wild type but not on target cells deficient in the 
transporter for antigen presentation (TAP). Two peptides (F1KYNGLIHR and RRSKEITVR_) 
loaded onto HLA-B*2705 molecules on TAP-deficient cells provided protection from lysis by 
NK cells expressing KIR-11 but three other B27-specific peptides did not. As the five peptides 
bound to HLA-B*2705 with similar stability, these data demonstrate that a single KIR specific 
for several HLA-B allotypes recognizes a subset ofpeptides bound to HLA-B*2705. 
H 
uman  NK  cells  express inhibitory receptors specific 
for distinct HLA-A, -B, and -C molecules (1-3). As a 
result of interaction with  HLA molecules on target cells, 
NK cells receive an inhibitory signal  through these recep- 
tors that prevents lysis  (reviewed in references 4-6).  The 
killer cell inhibitory receptors (KIP,) on NK cells comprise 
a family of molecules called p58 and p70 (2, 7) that belong 
to the Ig superfamily and are encoded by a family of genes 
on  human  chromosome  19  (8-10).  Soluble  recombinant 
forms of p58 KIR can directly bind to HLA-C molecules 
expressed on transfected cells (11). Expression of individual 
p58 KIR in NK clones using recombinant vaccinia viruses 
demonstrated  that  these  receptors  provide  both  specific 
recognition of HLA-C and the inhibitory signal  that pre- 
vents target cell lysis (11).  By use of the same vaccinia vi- 
res-mediated  expression  in  NK  clones,  a  p70  KIR  was 
shown  to recognize several HLA-B allotypes of the Bw4 
serological group  (11).  Another p70 KIR was reported to 
bind  to  HLA-A3  (12).  Most  NK  clones  that  express 
NKB1, a determinant shared by p70 KIR molecules reac- 
tive  with  mAb  DX9  (6,  7),  were  inhibited  by  HLA- 
B'2705  (13).  However,  recognition  of HLA-B*2705  by 
NK cells is complex in that several p70 molecules are reac- 
tive with DX9  and that recognition of HLA-B*2705 can 
also be mediated by receptors other than NKB1 (6, 7,  13). 
Recognition of HLA-B*2705 by NK cells was reported 
to involve some degree ofpeptide specificity (14). A group 
of HLA-B*2705-specific NK  clones recognized only one 
of four peptides  bound to HLA-B*2705 molecules expressed 
by RMA-S  or by T2  transporter for antigen  presentation 
(TAP)-deficient  cells  whereas  another  group  of  HLA- 
B*2705-specific NK clones failed to recognize any of the 
four peptides (14). More recently, we have shown that NK 
clones can recognize additional  unrelated peptides bound 
to  HLA-B*2705 but  not several other peptides  (14a). All 
the  peptides  tested  were  known  endogenous  ligands  of 
HLA-B*2705 molecules in human B cells. 
One puzzle raised by these findings is that KIP,. appear to 
be both broadly reactive and very specific at the same time. 
On the one hand, a single p70 KIlL (KIR-11  encoded by 
cDNA c1-11)  recognized several HLA-B allotypes (HLA- 
B'2705 and HLA-B*5101) on target cells (11) and, on the 
other hand, NK clones specific for HLA-B*2705 displayed 
selectivity for peptides (14,  14a).  Given that the p70 KIR 
are encoded by at least four different sequences (reviewed 
in reference 6)  and that individual NK clones can express 
multiple KIR (3,  8,  11,  15),  it was possible that different 
members  of the  p70  family  accounted  for  these  distinct 
specificities. 
To test whether discrimination among peptides  bound 
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whether peptide-specific recognition of HLA-B*2705 was 
a property carried by the same KIR that recognized other 
HLA-B  allotypes,  we  combined  two  experimental  ap- 
proaches.  First, HLA-B*2705 molecules on TAP-deficient 
cells were loaded with individual peptides and, second, NK 
clones that did not recognize HLA-B*2705 were infected 
with  recombinant vaccinia viruses encoding KIR-11.  We 
show  here  that  KIR-11  can discriminate among peptides 
bound to HLA-B*2705 molecules on TAP-deficient cells. 
Materials and Methods 
NK Clones and Cell Lines.  NK  clones  were  generated  from 
PBMC obtained by separation  on Ficoll-Hypaque. PBMC were 
washed with ice-cold PBS containing 1% BSA and 5 mM EDTA, 
and incubated with anti-CD3 mAb conjugated to magnetic mi- 
crobeads for 20 min at 4~  After one wash PBMC were passed 
through a MACS  |  column (Miltenyi Biotec Inc., Auburn, CA). 
The flow-through fraction was collected  and analyzed for purity 
by flow cytometry (<5% CD3 + T  cells). NK cells were cloned, 
expanded,  and maintained as described  (16). The human NK cell 
line NK-92  (gift of H.G.  Klingemann, Terry Fox Laboratory, 
Vancouver,  Canada)  was  cultured  as  described  (17, 18). The 
TAP-deficient T2 cells transfected  with HLA-B*2705  (T2-B27) 
and RMA-S transfected with the human ]32-microglobulin gene 
and with the HLA-B*2705  gene (RMA-S-B27) have been de- 
scribed  (19). These cell lines were maintained in Iscove's  modi- 
fied essential medium containing 10% FCS and 2 mM glutamine. 
RNIA-S (expressing human [32-microglobulin)  and T2-B27 were 
maintained in 0.5 mg/ml G418. RMA-S-B27 was maintained in 
0.5 mg/ml G418 and 250 U/ml hygromycin B. 
Antibodies and Immunostaining.  The  phenotype  of  NK  cells 
was deternfined as described  (16) with the anti-p58 mAbs EB6 
and GL183 (20, 21) (gift from A. Moretta, University of Genova, 
Genova, Italy), and the anti-p70 DX9  (7)  (gift from L.  Lanier, 
DNAX Research Institute, Palo Alto, CA). Surface expression of 
HLA-B*2705  molecules and of influenza virus hemagglutinin H3 
molecules was monitored with mAb ME. 1 (American Type Cul- 
ture  Collection, Rockville, MD)  and a pool  of anti-H3 mAbs 
(gift from R. Webster, St. Jude's Children's Hospital,  Memphis, 
TN), respectively. 2 ￿  10  s cells were incubated for 30 min on ice 
with the primary mAb, washed  in PBS containing 2% FCS, and 
stained with PE-conjugated goat  anti-mouse IgG1  (Jackson Im- 
munoResearch  Laboratories,  Inc.,  West  Grove,  PA),  washed 
twice, and analyzed on a FACScan  |  (Becton Dickinson and Co., 
Mountain View, CA). 
HLA-B*2705-specific  Peptides.  Peptides  were synthesized  and 
purified as described  (22). Purity was confirmed by analytical re- 
verse-phase  HPLC  and by mass spectrometry.  To  evaluate  the 
ability of each peptide to bind HLA-B*2705  molecules expressed 
on RMA-S-B27 and on T2-B27 cells, the surface level of HLA- 
B'2705 was measured by flow cytometry, after a 24-h incubation 
at 25~  in the absence or presence of each B*2705-specific pep- 
tide.  5  ￿  105 cells were incubated with peptides  added  at  two 
separate time points (onset of the culture and 12 h later) to reach 
a final concentration of 50 ~,M. To establish the stability of HLA- 
B'2705  surface  expression  induced  by  the  specific  peptides, 
RMA-S-B27 and T2-B27 cells were then harvested,  washed  at 
room temperature in PBS  containing 2%  FCS  to  remove  un- 
bound peptide,  and  divided into  three  aliquots.  Two  aliquots 
were incubated at 37~  the remaining one placed  on ice.  All- 
quots  were removed after  1 and 3 h at 37~  and placed  on ice. 
Surface levels of HLA-B*2705  were measured by flow cytometry 
using the mAb ME. 1 as described above. 
Vaccinia Virus Infections.  NK  clones  or  the  cell  line NK-92 
were infected for  1.5  h  with purified recombinant vaccinia  vi- 
ruses encoding KIR-11 (Vac-11) (11) or the influenza hemagglu- 
tinin H3 (Vac-H3)  (construct D in reference  23) as reported (11). 
Under the conditions used >90% of the cells expressed surface 
KIR-11 (5-10 PFU/cell) and ~>80% of the cells expressed surface 
H3 lnolecules (10-30 PFU/cell). In all experiments two different 
doses of PFU/cell were used for each vaccinia infection. 
Cytotoxicity Assay.  Frozen NK clones were thawed and cul- 
tured for 3-5 d in NK medium (Iscove's containing 10% human 
serum,  2  mM  glutamine, 50  U/ml  rlL-2  [gift of Hoffmann- 
LaRoche,  Nutley, NJ]) and 5% purified IL-2 (Schiapparelli Eni 
Diagnostic,  Fairfield, NJ) before being tested  in the SICr-release 
assay. NK cells infected with vaccinia as described above,  or un- 
infected were collected,  counted, resuspended  in Iscove's modi- 
fied essential medium containing 10% FCS, 2 mM glutamine, 5{) 
U/ml rlL-2, and plated  in a final volume of 100  btl in V-bot- 
tomed 96-well plates. NK clones were tested at several effector to 
target ratios in duplicate wells. During the last 12 h of the incuba- 
tion  with  peptide  at  25~  targets  were  labeled  with  sodium 
Slchromate  (100 b~Ci/well, Amersham Corp., Arlington Heights, 
IL). After two washes, cells were counted and resuspended at a fi- 
nal concentration of 2.5  ￿  104 cells/ml in RPMI 1640, 5% FCS, 
and 2 mM glutamine. 100 p,1 of the cell suspension were added to 
the NK clones and incubated in a 3-h SlCr-release killing assay (16). 
Single Strand Conformation Polymorphism.  First  strand cDNA was 
synthesized from total RNA of human NK clones and of NK-92 
as described  (8). PCR primers  and amplification  of p58  cDNA 
have been reported (8). For amplification of p70 cDNA the for- 
ward  and  backward  primers  were  GCCTCGAGGAGGACA- 
CACGT and GAGGGAGTTTTCTGTGGT,  respectively. PCR 
amplification  of p70 was as described  (8) except  that the anneal- 
ing temperature was 65~  instead  of 62~  Samples were elec- 
trophoresed on 6% nondenaturing  polyacrylamide  gels containing 
t0% glycerol, as described  (8). 
Results  and Discussion 
HLA-B* 2705 Molecules Loaded  with  Peptide FR YNGLIHR 
Inhibit NK Clones Expressing  the p 70 KIR- 1 I.  HLA-B*2705 
molecules  on  TAP-deficient  cells  loaded  with  peptide 
FRYNGLIHR  inhibited lysis  by some  but not by  other 
NK clones, even though all NK clones tested were inhib- 
ited by HLA-B*2705 on wild-type cells,  such as C1R-B27 
(14). To test whether KIR-11, known to recognize HLA- 
B'2705 and HLA-B*5101  (11),  was able to  recognize the 
peptide FRYNGLIHR bound to HLA-B*2705 molecules 
on TAP-deficient cells,  two NK clones that did not recog- 
nize HLA-B*2705 were  selected for vaccinia virus-medi- 
ated expression of KIR-11. These NK clones did not ex- 
press p58 and pT0 KIR reactive with mAbs EB6,  GL183, 
and DX9,  and they lysed C1R,  C1R-B27,  RMA-S,  and 
RMA-S-B27 cells  (data not shown).  To control for non- 
specific  inhibition of lysis caused by vaccinia virus infec- 
tion, target cell lysis by each NK clone was tested in three 
different conditions: with uninfected NK clones, with  NK 
clones after infection by a  control vaccinia virus encoding 
the influenza virus hemagglutinin H3 molecule (Vac-H3), 
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Figure  2.  Discrimination  among  several peptides  bound  to  HLA- 
B'2705 by NK clones expressing KIR-11. Lysis of RMA-S-B27 cells by 
the two indicated NK clones infected with Vac-H3 (hatched bars) or with 
Vac-ll (filled  bars). Target cells were preincubated at 25~  for 24 h with- 
out or with the indicated peptides. The data are expressed as lysis of tar- 
gets in the presence of peptide relative to the lysis of the same targets in 
the absence ofpeptide given as the average of two to five experiments for 
each peptide. The bars represent the SEM. 
E:T ratio 
Figure 1.  Expression of KIR-11 in NK clones confers recognition  of 
HLA-B*2705 molecules loaded with peptide  FRYNGLIHR. (A) Flow 
cytometry analysis of NK clone 5w-A06 either uninfected, infected with 
30 PFU/cell of Vac-H3, or infected with 10 PFU/cell ofVac-11, as indi- 
cated.  Cells were  stained with  anti-H3 mAb or anti-p70 mAb DX9. 
Identical results were obtained with NK clone 10w-A18. (B) NK clone 
5w-A06 infected with Vac-H3  (circle.s)  or Vac-11 (squares) was tested for 
its ability to lyse RMA-S (left) and I~MA-S-B27 (night) cells. Target cells 
were preincubated at 25~  for 24 h in the absence or presence ofpeptide 
FRYNGLIHR, as indicated.  Similar results were  obtained in other ex- 
periments with this and another NK clone (10w-A18). 
or by a vaccinia virus encoding KIR-11  (Vac-11).  Infected 
NK clones expressed uniform surface levels of H3 or KIR- 
11  (Fig.  1 A). RMA-S  cells were lysed by NK clones in all 
the conditions even after incubation with peptide FRYN- 
GLIHR  (Fig.  1 B). RMA-S-B27  cells were protected from 
lysis  by  NK  clones  only  after  incubation  with  peptide 
FRYNGLIHR  and  only after  infection of NK  clones by 
Vac-11  (Fig.  1 B), Therefore, expression of KIR-11 in NK 
clones resulted  in specific  recognition of peptide  FRYN- 
GLIHR  in  the  context  of  HLA-B*2705  molecules  ex- 
pressed on target cells. 
Functional  Transfer Of KIR-11  into NK Clones  Confers Rec- 
ognition  of  a  Subset  of  Peptides  Bound  to  HLA-B*2705. 
Five  different  B*2705-specific  peptides,  corresponding  to 
endogenous peptides associated with HLA-B*2705 on nor- 
mal  cells  (24),  were  tested  for  their  ability to  inhibit NK 
clones  expressing  KIR-11  (Fig.  2).  In  a  separate  study 
(14a),  we showed that all five peptides caused a  similar in- 
crease in surface HLA-B*2705  molecules on RMA-S-B27 
cells and conferred to HLA-B*2705 molecules a similar sta- 
bility  at  37~  but  that  only  two  of  the  five  peptides 
(FRYNGLIHR  and  RRSKEITVR)  provided  protection 
from lysis by a panel ofB27-specific NK clones. Vac-11 in- 
fection  of NK  clones  resulted  in  the  recognition  of the 
same two  peptides bound to  HLA-B*2705  (Fig.  2).  These 
two peptides did not provide protection from lysis by Vac- 
H3  infected  NK  clones  and  the  other  three  peptides  did 
not provide protection under any condition. These  results 
demonstrate  that  KIR-11  can  distinguish  among  HLA- 
B'2705  molecules loaded  with  different  peptides  and  that 
expression of KIR-11  confers to  NK  clones specificity for 
at least two peptides that are unrelated by sequence. There- 
fore,  recognition  of different  peptides  in  the  context  of 
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Figure 4.  Expression  of KIR-11 in the KIR-negative cell line NK-92 
confers peptide-specific recognition of HLA-B*2705. NK-92 cells were 
infected with 10 PFU/cell of Vac-ll. T2 and T2-B27 target cells were 
preincubated at 25~  for 24 h in the absence (triangles) or in the presence 
of peptide FRYNGLIHR  (circles) or peptide RRYQKSTEL  (squares). 
Similar results were obtained in two other experiments. 
Figure 3.  Expression  ofKIR mRNA in different NK cells. SSCP anal- 
ysis of PCR amplification  products derived from plasmids encoding p58 
or p70 and from mRNA of the indicated NK cells. (A) SSCP pattern of 
p58 in the indicated NK cells. The picture was generated from different 
exposures of the same gel. (B) SSCP pattern of p70 in the indicated NK 
cells. The picture was generated from a single  exposure of one gel. 
HLA-B*2705  is  not  mediated by  a  distinct KIR for  each 
peptide but by a single KIR. 
Expression  of KIR-11  in  the  Cell  Line  NK-92  Results  in 
Peptide-spedfic Recognition of  HLA-B*2705.  Human NK clones 
express at least one, and often several different KItK (3,  8, 
15).  The  presence  of multiple  KIR  in  NK  clones  may 
complicate the  assignment of specificity to  a  single KIR, 
even though the NK clones used in the vaccinia virus in- 
fections described above did not express molecules reactive 
with  anti-KIR mAbs. The  presence of mRNA  encoding 
KIR was analyzed by single strand conformation polymor- 
phism  (SSCP)  in the  two  NK clones (5w-A06 and  10w- 
A18) used in the infection experiments described above, in 
two  control NK  clones  (SR-59  and  SR-62)  that  express 
KIR, and in NK-92, an NK cell line (17)  that does not ex- 
press KIR reactive with available mAbs and that has been 
used to reconstitute KIR function (18). 
NK  clones  5w-A06  and  10w-A18  expressed  only one 
p58  receptor  (corresponding to  cl-39)  but  no  detectable 
p70 Kilt. (Fig. 3, A  and B).  NK clones SR-59 and SR-62 
expressed  several p58  and p70  receptors.  In contrast,  the 
NK-92 cell line did not detectably express any known p58 
or  p70  molecule.  Therefore,  NK-92  was  infected  with 
Vac-ll  to  determine whether KIR-11  could confer pep- 
tide-specific  recognition of HLA-B27  in  the  absence  of 
other known members of the KIR family. Lysis of the hu- 
man TAP-deficient cells T2-B27 by NK-92 was more effi- 
cient than that of RMA-S-B27 (70 and 30% lysis,  respec- 
tively, at  an E/T  ratio  of 6,  data  not shown).  Therefore, 
T2-B27 cells were used to test for peptide-specific recogni- 
tion by NK-92 after vaccinia virus infections. As shown for 
NK clones, NK-92 ceils expressed uniform surface levels of 
H3 and KIR-11 after infections with the relevant vaccinia 
viruses (not shown). T2-B27 cells were protected from lysis 
by  NK-92  only  after  incubation with  peptide  FRYN- 
GLIHR (Fig.  4).  Peptide RRYQKSTEL did not provide 
protection,  despite  its  ability  to  stabilize  surface  HLA- 
B'2705 molecules on T2-B27 cells (Table 1).  The protec- 
tive  effect  of peptide  FRYNGLIHR  was  dependent  on 
HLA-B*2705 molecules because it did not protect T2 cells. 
All  cells  were  lysed  indiscriminately by  Vac-H3-infected 
Table 1.  Stability of HLA-B*2705 Molecules on T2-B27 Cells 
Hours at 37~ 
Peptide  0  1  3 
None  84  50  42 
FRYNGLIHR  119  103  100 
RRYQKSTEL  145  101  101 
T2-B27 cells were incubated at 25~  for 24 h in the absence or in the 
presence of peptide, washed, and incubated at 37~  for the indicated 
time. Surface levels of HLA-B*2705 were measured by flow cytometry 
using the B*2705-specific n~Ab  ME. 1. The data are expressed as median 
fluroescence intensity. 
1588  Peptide Discrimination by HLA-B-specific Killer Cell Inhibitory Receptor NK-92  cells  (not  shown).  Thus,  discrimination  among 
peptides  bound  to  HLA-B*2705  molecules  was  achieved 
by KI1K-11 expressed in the cell line NK-92. 
Condusions.  The combination of two experimental sys- 
tems,  TAP-deficient  cells  whose  class  I  molecules  can  be 
loaded  with  defined  peptides  and  reconstitution  of KIlL 
function  by  vaccinia  virus-mediated  expression  in  NK 
clones,  made  it  possible  to  test  the  specificity  of a  single 
KIlL for peptides bound to HLA-B*2705. The data clearly 
showed  that  a  single  p70  KIP,,  discriminates  among pep- 
tides bound to HLA-B*2705 molecules. Somewhat surpris- 
ingly,  KIR-11  is  the  same  receptor  that inhibits  NK  cells 
upon interaction  with  different allotypes  of the Bw4 sub- 
group (11).  It xvfill be interesting to test whether recognition 
of other HLA-Bw4 allotypes by KIR-11  is also influenced 
by  peptide  sequences.  KIR-11  recognized  HLA-B*2705 
molecules loaded with two different peptides  almost com- 
pletely  unrelated  by  sequence.  This  permissive  peptide 
specificity ofKIR-11 is quite distinct from the fine peptide 
specificity typically displayed by T  cell receptors  and from 
the lack of peptide  specificity of the mouse NK inhibitory 
receptor Ly49A (25). These results suggest a different mode 
of interaction with MHC  class  I for KILL, Ly49, and TCR 
molecules. 
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